{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:07:16Z","timestamp":1790388436218,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T00:00:00Z","timestamp":1459728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s12032-016-0760-x","type":"journal-article","created":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T12:12:55Z","timestamp":1459771975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Tatsuya","family":"Takayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Saya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,4]]},"reference":[{"issue":"3","key":"760_CR1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","volume":"19","author":"T Ishimoto","year":"2011","unstructured":"Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T, Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, Baba Y, Ohmura M, Suematsu M, Baba H, Saya H. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell. 2011;19(3):387\u2013400.","journal-title":"Cancer Cell"},{"issue":"6","key":"760_CR2","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1158\/0008-5472.CAN-12-3609-T","volume":"73","author":"M Yoshikawa","year":"2013","unstructured":"Yoshikawa M, Tsuchihashi K, Ishimoto T, Yae T, Motohara T, Sugihara E, Onishi N, Masuko T, Yoshizawa K, Kawashiri S, Mukai M, Asoda S, Kawana H, Nakagawa T, Saya H, Nagano O. xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma. Cancer Res. 2013;73(6):1855\u201366.","journal-title":"Cancer Res"},{"issue":"10","key":"760_CR3","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.leu.2402238","volume":"15","author":"PW Gout","year":"2001","unstructured":"Gout PW, Buckley AR, Simms CR, Bruchovsky N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia. 2001;15(10):1633\u201340.","journal-title":"Leukemia"},{"issue":"49","key":"760_CR4","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1038\/onc.2015.60","volume":"34","author":"L Sleire","year":"2015","unstructured":"Sleire L, Skeie BS, Netland IA, F\u00f8rde HE, Dodoo E, Selheim F, Leiss L, Heggdal JI, Pedersen PH, Wang J, Enger P\u00d8. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc(-), leading to glutathione depletion. Oncogene. 2015;34(49):5951\u20139.","journal-title":"Oncogene"},{"issue":"1","key":"760_CR5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2015.07.031","volume":"368","author":"MZ Ma","year":"2015","unstructured":"Ma MZ, Chen G, Wang P, Lu WH, Zhu CF, Song M, Yang J, Wen S, Xu RH, Hu Y, Huang P. Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism. Cancer Lett. 2015;368(1):88\u201396.","journal-title":"Cancer Lett"},{"issue":"7","key":"760_CR6","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1158\/1078-0432.CCR-13-2805","volume":"20","author":"RM Drayton","year":"2014","unstructured":"Drayton RM, Dudziec E, Peter S, Bertz S, Hartmann A, Bryant HE, Catto JW. Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine\/glutamate exchanger SLC7A11. Clin Cancer Res. 2014;20(7):1990\u20132000.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"760_CR7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/pros.20508","volume":"67","author":"DW Doxsee","year":"2007","unstructured":"Doxsee DW, Gout PW, Kurita T, Lo M, Buckley AR, Wang Y, Xue H, Karp CM, Cutz JC, Cunha GR, Wang YZ. Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate. 2007;67(2):162\u201371.","journal-title":"Prostate"},{"issue":"10","key":"760_CR8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/cas.12236","volume":"104","author":"T Wada","year":"2013","unstructured":"Wada T, Ishimoto T, Seishima R, Tsuchihashi K, Yoshikawa M, Oshima H, Oshima M, Masuko T, Wright NA, Furuhashi S, Hirashima K, Baba H, Kitagawa Y, Saya H, Nagano O. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia. Cancer Sci. 2013;104(10):1323\u20139.","journal-title":"Cancer Sci"},{"issue":"7","key":"760_CR9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/pros.20928","volume":"69","author":"GS Palapattu","year":"2009","unstructured":"Palapattu GS, Wu C, Silvers CR, Martin HB, Williams K, Salamone L, Bushnell T, Huang LS, Yang Q, Huang J. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer. Prostate. 2009;69(7):787\u201398.","journal-title":"Prostate"},{"key":"760_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1538-7445.AM2014-211","volume":"74","author":"K Shitara","year":"2014","unstructured":"Shitara K, Takahashi S, Nakajima T, Hironaka S, Nagano O, Imamura C, Mushiroda T, Einaga Y, Fukunani M, Sato A, Ohtsu A, Saya H, Doi T. Sulfasalazine (SSZ) works cancer stem-like cells (CSCs) via inhibiting xCT signal pathway: phase 1 study in patients with gastric cancer (EPOC 1205). Cancer Res. 2014;74:211.","journal-title":"Cancer Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-016-0760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-016-0760-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-016-0760-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:31:56Z","timestamp":1559428316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-016-0760-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,4]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["760"],"URL":"https:\/\/doi.org\/10.1007\/s12032-016-0760-x","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,4]]},"article-number":"45"}}